Translate Sign in JOIN

MDR-TB Treatment & Prevention

MOTT

I appreciate all the great responses. Currently, we will not be treating MOTT even if on 2 samples or more. We cannot speciate because of lack of resources, so no point in treating. If anything changes, will post here. And please feel free to add more…

By Vivian Huang, MD, MPH on 20 Mar 2013 1 Recommendations 6 Replies

"Resistant TB: Use Available Tools Now" Nature Correspondence

The ICN TB Project has a full set of training materials based on the transformational training and education methodology which we have developed over the last 8 years. I am willing to share these if people contact me directly. The way we train is very…

By Agnès Binagwaho, MD, M(Ped) on 13 Feb 2013 1 Recommendations 14 Replies

New cochrane systematic review on Xpert MTB/RIF

http://www.cochrane.org/podcasts/issue-1-january-2013/xpert-mtbrif-test-detection-pulmonary-tuberculosis-and-rifampicin-resi

By Shubhada Shenai on 31 Jan 2013 1 Recommendations 0 Replies

Start of 2013 and short introduction of members

Dear All I wish to make some corrections on the consultancy i shared earlier: Development of a* *regional *"P**olicy on Management of M/XDR TB Failures"*for the ECSA region Rgds

By Masoud Dara, MD on 07 Jan 2013 2 Recommendations 36 Replies

Expert Panel Dec. 10-14: Scaling-up GeneXpert MTB/RIF

We have used cartridges beyond the expiry date and those worked just fine.I guess you could use them,you'd just have to change the date in the system so it would accept these cartridges.

By Sophie Beauvais on 08 Dec 2012 2 Recommendations 86 Replies

MSF: Standard TB test failing to detect the disease in children 93% of the time

Standard TB test failing to detect the disease in children 93% of the time New MSF multinational study of paediatric TB/HIV co-infection confirms crisis of undiagnosed TB among children Geneva/Kuala Lumpur, 15 November 2012 – Data from the largest-ever…

By Joanna Keenan on 15 Nov 2012 1 Recommendations 0 Replies

Expert Panel Apr. 2-6: Implementing Quality Management Systems to Strengthen Laboratory Capacity

In response to Regina Bhebhe, I acted in a mentoring capacity in Zimbabwe and many other places around the world and I would observe that it is very difficult for people to understand the enormous cultural change that is required to adopt the demands of…

By Sophie Beauvais on 01 Apr 2012 3 Recommendations 31 Replies

Expert Panel Feb. 20-24: Management of Second Line anti-TB Drugs: Getting it right

Dr Dara, Dr DitiuI, Dr Lunte, Dr Jaramillo, I read the WHO 2011 TB report with great interest. While the global TB picture is scary, I believe that a great progress has been made towards reducing the burden of TB, thanks to the concerted efforts of WHO and…

By Sophie Beauvais on 19 Feb 2012 6 Recommendations 61 Replies

Challenges in Rolling-out the GeneXpert MTB/RIF Diagnostic Test in Resource-Limited Settings - May 9-20

Thank you for your replies here. They were really helpful. Just wanted to ask if the system would take the cartridge and not reject it because we were just planning to use them for some training purpose, definitely not for patient care. Thanks a lot.…

By Sophie Beauvais on 09 May 2011 1 Recommendations 67 Replies

Smear positive but culture negative

Exactly ntate Alabi. Good to hear from you

By Mostafizur Rahman on 29 Jan 2011 1 Recommendations 16 Replies
More posts
Join this community Community news feed

About this community

In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD - WHO Europe - EURO

Christopher Gilpin, PhD, MPH - World Health Organization - WHO

Community topics